Pacira BioSciences (PCRX) Revenue (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Revenue of $177.4 million for Q1 2026, up 5.0% year-over-year from $168.9 million in Q1 2025, and down 9.9% quarter-over-quarter from $196.9 million in Q4 2025.
Pacira BioSciences (PCRX) Revenue (2010 - 2026) Analysis & Trends
Pacira BioSciences' Revenue history runs 17 years deep, the most recent figure standing at $177.4 million for Q1 2026.
- In Q1 2026, Revenue rose 5.0% year-over-year to $177.4 million; the TTM figure through Mar 2026 stood at $734.9 million (up 4.57% YoY), while the FY2025 annual figure was $726.4 million, up 3.63% from the prior year.
- Revenue for Q1 2026 stood at $177.4 million, down from $196.9 million in the prior quarter.
- The five-year high for Revenue was $196.9 million in Q4 2025, with the low at -$492.2 million in Q4 2022.
- The 5-year median for Revenue is $169.4 million (2022), against an average of $134.3 million.
- The sharpest annual moves came in 2022 and 2023: Revenue sank 409.18% in 2022, then surged 136.82% in 2023.
- Pacira BioSciences' Revenue stood at -$492.2 million in 2022, then jumped by 136.82% to $181.2 million in 2023, then increased by 3.32% to $187.3 million in 2024, then increased by 5.14% to $196.9 million in 2025, then dropped by 9.9% to $177.4 million in 2026.
- Business Quant data shows PCRX's Revenue at $177.4 million in Q1 2026, $196.9 million in Q4 2025, and $179.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Pacira BioSciences | 951.43 Mn | 700.40 Mn | 148.24 Mn | 192.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 192.40 Mn |
| Mar 31, 2026 | 177.38 Mn |
| Dec 31, 2025 | 196.87 Mn |
| Sep 30, 2025 | 179.52 Mn |
| Jun 30, 2025 | 181.10 Mn |
| Mar 31, 2025 | 168.92 Mn |
| Dec 31, 2024 | 187.25 Mn |
| Sep 30, 2024 | 168.57 Mn |
| Jun 30, 2024 | 178.02 Mn |
| Mar 31, 2024 | 167.12 Mn |
| Dec 31, 2023 | 181.24 Mn |
| Sep 30, 2023 | 163.93 Mn |
| Jun 30, 2023 | 169.47 Mn |
| Mar 31, 2023 | 160.34 Mn |
| Dec 31, 2022 | -492.20 Mn |
| Sep 30, 2022 | 167.47 Mn |
| Jun 30, 2022 | 169.41 Mn |
| Mar 31, 2022 | 157.99 Mn |
| Dec 31, 2021 | 159.19 Mn |
| Sep 30, 2021 | 127.72 Mn |